News & Articles

Access SARS-CoV-2 IgG assay shows excellent agreement with the Genscript Surrogate Virus Neutralization Test

Fluidigm COVID-19 campus safeguard program improves availability of non-invasive, saliva-based SARS-CoV-2 tests for higher education institutions

Join us on Monday, October 19, to find out how targeting BCMA and GPRC5D simultaneously could help to prevent tumor cell escape

Researchers have made a significant COVID-19 drug target discovery using Thermo Fisher Scientific CryoEM technology

Affimer-based research assay launched alongside performance data published by Bruker

Explore our roundup of key considerations for a successful CRISPR/Cas9 experiment

Early surgical treatment of leg ulcers caused by varicose veins improves healing and reduces the risk of the condition coming back

Menu of test solutions for infectious diseases – which already includes COVID-19 – to be expanded, especially in the U.S.

Promega and Incyte intend to work together in the future to develop the Promega OncoMate MSI Assay as a companion diagnostic

The Direct assay is validated on a wide range of specimen types, and can be run in parallel with the Simplexa Flu A/B & RSV Direct Gen II assay

cPass is first commercially available product to rapidly detect neutralizing antibodies capable of eliminating virus

The new line aims to provide unmatched sensitivity, resolution, speed, and flexibility of colors

Emergency scans captured images of the top of the lungs where a fluffiness known as ‘ground glass opacification’ allowed COVID-19 to be diagnosed

AstraZeneca anticipates entering clinical development in 2021

The technology is said to be superior at identifying cell types in human blood, providing faster and more reliable assessments for clinical decision making

The new Elecsys Anti-SARS-CoV-2 S test can quantitatively measure the level of antibodies against SARS-CoV-2 in patients who have been exposed to the virus

The partnership aims to co-market exosome technology as well as the joint development of new exosome based products

The collaboration aims to define threshold for neutralizing antibody sufficient to confer immunity

New indication allows this first FDA-approved biomarker-based test to be used as triage for positive cobas HPV tests run on cobas 6800/8800 Systems in primary screening or co-testing programs

Access Anti-SARS-CoV-2 Antigen Test, developed in collaboration with Ellume, aims to provide accurate results in less than 15 minutes

Agreements with AstraZeneca and the University of Nebraska Medical Center showcase new workflows to improve the throughput, robustness and standardization of clinical biomarker analysis

The agreement is part of preparations for GMP production of material for the first clinical study of CG01

Watch this on-demand webinar to discover the critical factors when choosing an assay for coronavirus testing

Join us on Monday, September 21, to learn about assay development for high-throughput screening

New research published in Nature Immunology show strong T cell responses in patients recovered from COVID-19